ACC's leadership is in Chicago for AHA's meeting, and working hard for our members. We're representing ACC at international events such a the meeting of the American Association of Cardiologists of Indian Origin. When my wife and I retired from the meetings for a quiet Sunday evening dinner, Jack Lewin and former ACC President Fred Bove led into the restaurant an ACC contingent that spilled over discussions from the JACC Journals Reception earlier in the evening.

Late breaking clinical trials presented yesterday at AHA -- including ASCEND-HF, RAFT, ADVANCE and EMPHASIS-HF -- are nicely summarized on CardioSource for those not in Chicago. There were more late breaking trials today, as well as an interesting session chaired by ACC BOT Elliot Antman that will cover regulatory issues that intersect with the clinical use of clopidogrel and warfarin.